Business
AIM Rule 26 & Adviser Name
AIM Rule 26 & Adviser Name.
About this update from Proteome Sciences Plc
[{"type":"text","content":"\n \n \n\n \n\nProteome Sciences Plc (\"Proteome Sciences\" or \"the Company\")\n\n \n\n17 August 2007\n\n \n\nAIM Rule 26 Compliant Website and Change of Adviser Name\n\n \n\n \nProteome Sciences plc (\"Proteome Sciences\") today announces that the information required by Rule 26 \nof the AIM Rules for Companies (February 2007) is available within the \"Rule 26\" section of the \nCompany's website at www.proteomics.com \n\nThe Company today also announces that with effect from 9 August 2007, the name\nof the Company's nominated adviser and broker has changed to Landsbanki\nSecurities (UK) Limited.\n\n \n\n \n\nEnds\n\n \n\nNotes to editors:\n\n \n\nProteome Sciences plc applies high sensitivity proteomics to identify and\ncharacterise differential protein expression in diseases for diagnostic,\nprognostic and therapeutic applications. It has discovered blood biomarkers\nprincipally for stroke, vCJD, BSE, brain damage, solid organ transplant\nrejection and Alzheimer's disease. The main focus of its research currently\naddresses neurological, neurodegenerative, oncology and cardiovascular\nconditions.\n\n \n\nIn addition to its own proprietary biomarkers, Proteome Sciences has developed\nProteoSHOP® (Proteome Sciences High Output Proteomics), a toolbox that offers\nhigh sensitivity and high throughput gel and gel-free proprietary technologies\nfor the identification and validation of potential biomarkers and drug targets,\nincluding specialisation in membrane proteins and protein phosphorylation. \n\n \n\nThe Company has developed a range of specialist reagents to improve the\nperformance and quantitation of protein separation and characterisation with\nmass spectrometry, bioinformatics, statistics and pattern recognition. These\ninclude Sensitizer®, PST®, qPST™ and TMT®. Proteome Sciences has patent\nallowances in the major global jurisdictions for isobaric tandem mass tags (TMT\n®) for the manufacture and use of any type of isobaric mass tags.\n\n \n\nCommercialisation is actively pursued across the portfolio of the Company's\nprogrammes and technologies with licensing deals signed in biomarkers for\nStroke and TSEs and for ProteoSHOP®.\n\n \n\n \n\n \n\n \n\n \n\nProteome Sciences has its headquarters in Cobham, Surrey in the UK and has\nlaboratories at Kings College Hospital, London and Frankfurt Innovations\nZentrum ...